Ceramide-rich platforms in transmembrane signaling

FEBS Letters

Volumn 584, Issue 9, 2010, Pages 1728-1740

  Stancevic, Branka ^a   Kolesnick, Richard ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

ASMase; Ceramide; Platforms

Indexed keywords

ANTINEOPLASTIC AGENT; CD40 ANTIGEN; CERAMIDE; LYSOSOME ENZYME; MEMBRANE LIPID; PROTEIN ASMASE; RECOMBINANT ASMASE; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; BILAYER MEMBRANE; BIOPHYSICS; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; DIFFUSION; ENZYME ACTIVATION; HUMAN; INFERTILITY; INTERNALIZATION; LIPID MEMBRANE; LIPID RAFT; MEMBRANE BIOLOGY; MEMBRANE FUSION; MEMBRANE STABILIZATION; MEMBRANE STRUCTURE; MEMBRANE TRANSPORT; NONHUMAN; PHOSPHOLIPID MEMBRANE; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LIPID INTERACTION; PROTEIN TARGETING; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; TUMOR; VASCULAR DISEASE; ANIMAL; CHEMISTRY; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; LIPID METABOLISM; MEMBRANE FLUIDITY; METABOLISM; PHASE TRANSITION; PHYSIOLOGY;

ANIMALS; CELL MEMBRANE PERMEABILITY; CERAMIDES; HUMANS; LIPID METABOLISM; LIPID METABOLISM DISORDERS; MEMBRANE FLUIDITY; MEMBRANE FUSION; MEMBRANE MICRODOMAINS; PHASE TRANSITION; SIGNAL TRANSDUCTION;

EID: 77951910348     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.02.026     Document Type: Review

References (159)

1. Hannun Y.A., Bell R.M. Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses. Science 1987, 235:670-674.
2. Kolesnick R.N. 1,2-Diacylglycerols but not phorbol esters stimulate sphingomyelin hydrolysis in GH3 pituitary cells. J. Biol. Chem. 1987, 262:16759-16762.
3. Kolesnick R.N., Clegg S. 1,2-Diacylglycerols, but not phorbol esters, activate a potential inhibitory pathway for protein kinase C in GH3 pituitary cells. Evidence for involvement of a sphingomyelinase. J. Biol. Chem. 1988, 263:6534-6537.
4. Kolesnick R.N. Sphingomyelinase action inhibits phorbol ester-induced differentiation of human promyelocytic leukemic (HL-60) cells. J. Biol. Chem. 1989, 264:7617-7623.
5. Goni F.M., Alonso A. Effects of ceramide and other simple sphingolipids on membrane lateral structure. Biochim. Biophys. Acta 2009, 1788:169-177.
6. Goni F.M., Alonso A. Biophysics of sphingolipids I. Membrane properties of sphingosine, ceramides and other simple sphingolipids. Biochim. Biophys. Acta 2006, 1758:1902-1921.
7. Zhang Y., Li X., Becker K.A., Gulbins E. Ceramide-enriched membrane domains-structure and function. Biochim. Biophys. Acta 2009, 1788:178-183.
8. Jenkins G.M., Richards A., Wahl T., Mao C., Obeid L., Hannun Y. Involvement of yeast sphingolipids in the heat stress response of Saccharomyces cerevisiae. J. Biol. Chem. 1997, 272:32566-32572.
9. Dickson R.C., Nagiec E.E., Skrzypek M., Tillman P., Wells G.B., Lester R.L. Sphingolipids are potential heat stress signals in Saccharomyces. J. Biol. Chem. 1997, 272:30196-30200.
10. Deng X., et al. Ceramide biogenesis is required for radiation-induced apoptosis in the germ line of C. elegans. Science 2008, 322:110-115.
11. Menuz V., et al. Protection of C. elegans from anoxia by HYL-2 ceramide synthase. Science 2009, 324:381-384.
12. Rao R.P., et al. Ceramide transfer protein function is essential for normal oxidative stress response and lifespan. Proc. Natl. Acad. Sci. USA 2007, 104:11364-11369.
13. Kolesnick R.N., Goni F.M., Alonso A. Compartmentalization of ceramide signaling: physical foundations and biological effects. J. Cell Physiol. 2000, 184:285-300.
14. Sot J., Goni F.M., Alonso A. Molecular associations and surface-active properties of short- and long-N-acyl chain ceramides. Biochim. Biophys. Acta 2005, 1711:12-19.
15. Sot J., Aranda F.J., Collado M.I., Goni F.M., Alonso A. Different effects of long- and short-chain ceramides on the gel-fluid and lamellar-hexagonal transitions of phospholipids: a calorimetric, NMR, and X-ray diffraction study. Biophys. J. 2005, 88:3368-3380.
16. Small D.M. Surface and bulk interactions of lipids and water with a classification of biologically active lipids based on these interactions. Fed. Proc. 1970, 29:1320-1326.
17. Futerman A.H., Hannun Y.A. The complex life of simple sphingolipids. EMBO Rep. 2004, 5:777-782.
18. Bouwstra J.A., Ponec M. The skin barrier in healthy and diseased state. Biochim. Biophys. Acta 2006, 1758:2080-2095.
19. Kolesnick R. The therapeutic potential of modulating the ceramide/sphingomyelin pathway. J. Clin. Invest. 2002, 110:3-8.
20. Duan R.D. Alkaline sphingomyelinase: an old enzyme with novel implications. Biochim. Biophys. Acta 2006, 1761:281-291.
21. Shimeno H., Soeda S., Yasukouchi M., Okamura N., Nagamatsu A. Fatty acyl-Co A: sphingosine acyltransferase in bovine brain mitochondria: its solubilization and reconstitution onto the membrane lipid liposomes. Biol. Pharm. Bull. 1995, 18:1335-1339.
22. Bionda C., Portoukalian J., Schmitt D., Rodriguez-Lafrasse C., Ardail D. Subcellular compartmentalization of ceramide metabolism: MAM (mitochondria-associated membrane) and/or mitochondria?. Biochem. J. 2004, 382:527-533.
23. Kirschnek S., et al. CD95-mediated apoptosis in vivo involves acid sphingomyelinase. J. Biol. Chem. 2000, 275:27316-27323.
24. Schissel S.L., et al. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development. J. Biol. Chem. 1998, 273:2738-2746.
25. Geeraert L., Mannaerts G.P., van Veldhoven P.P. Conversion of dihydroceramide into ceramide: involvement of a desaturase. Biochem. J. 1997, 327(Pt 1):125-132.
26. Lahiri S., Lee H., Mesicek J., Fuks Z., Haimovitz-Friedman A., Kolesnick R.N., Futerman A.H. Kinetic characterization of mammalian ceramide synthases: determination of K(m) values towards sphinganine. FEBS Lett. 2007, 581:5289-5294.
27. Kitatani K., Idkowiak-Baldys J., Hannun Y.A. The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell Signal. 2008, 20:1010-1018.
28. Valaperta R., Chigorno V., Basso L., Prinetti A., Bresciani R., Preti A., Miyagi T., Sonnino S. Plasma membrane production of ceramide from ganglioside GM3 in human fibroblasts. FASEB J. 2006, 20:1227-1229.
29. Kolesnick, R. and Hannun, Y.A. (1999). Ceramide and apoptosis. Trends Biochem. Sci. 24, 224-225; author reply 227.
30. Holopainen J.M., Lehtonen J.Y., Kinnunen P.K. Lipid microdomains in dimyristoylphosphatidylcholine-ceramide liposomes. Chem. Phys. Lipids 1997, 88:1-13.
31. Holopainen J.M., Subramanian M., Kinnunen P.K. Sphingomyelinase induces lipid microdomain formation in a fluid phosphatidylcholine/sphingomyelin membrane. Biochemistry 1998, 37:17562-17570.
32. Massey J.B. Interaction of ceramides with phosphatidylcholine, sphingomyelin and sphingomyelin/cholesterol bilayers. Biochim. Biophys. Acta 2001, 1510:167-184.
33. Hsueh Y.W., Giles R., Kitson N., Thewalt J. The effect of ceramide on phosphatidylcholine membranes: a deuterium NMR study. Biophys. J. 2002, 82:3089-3095.
34. Huang H.W., Goldberg E.M., Zidovetzki R. Ceramide induces structural defects into phosphatidylcholine bilayers and activates phospholipase A2. Biochem. Biophys. Res. Commun. 1996, 220:834-838.
35. Huang H.W., Goldberg E.M., Zidovetzki R. Ceramides perturb the structure of phosphatidylcholine bilayers and modulate the activity of phospholipase A2. Eur. Biophys. J. 1998, 27:361-366.
36. Veiga M.P., Arrondo J.L., Goni F.M., Alonso A. Ceramides in phospholipid membranes: effects on bilayer stability and transition to non-lamellar phases. Biophys. J. 1999, 76:342-350.
37. Silva L., de Almeida R.F., Fedorov A., Matos A.P., Prieto M. Ceramide-platform formation and induced biophysical changes in a fluid phospholipid membrane. Mol. Membr. Biol. 2006, 23:137-148.
38. Sot J., Bagatolli L.A., Goni F.M., Alonso A. Detergent-resistant, ceramide-enriched domains in sphingomyelin/ceramide bilayers. Biophys. J. 2006, 90:903-914.
39. Nurminen T.A., Holopainen J.M., Zhao H., Kinnunen P.K. Observation of topical catalysis by sphingomyelinase coupled to microspheres. J. Am. Chem. Soc. 2002, 124:12129-12134.
40. Chiantia S., Kahya N., Ries J., Schwille P. Effects of ceramide on liquid-ordered domains investigated by simultaneous AFM and FCS. Biophys. J. 2006, 90:4500-4508.
41. Johnston I., Johnston L.J. Ceramide promotes restructuring of model raft membranes. Langmuir 2006, 22:11284-11289.
42. Johnston I., Johnston L.J. Sphingomyelinase generation of ceramide promotes clustering of nanoscale domains in supported bilayer membranes. Biochim. Biophys. Acta 2008, 1778:185-197.
43. Ira, Zou, S., Ramirez, D.M., Vanderlip, S., Ogilvie, W., Jakubek, Z.J. and Johnston, L.J. (2009). Enzymatic generation of ceramide induces membrane restructuring: Correlated AFM and fluorescence imaging of supported bilayers. J. Struct. Biol.
44. Ruiz-Arguello M.B., Basanez G., Goni F.M., Alonso A. Different effects of enzyme-generated ceramides and diacylglycerols in phospholipid membrane fusion and leakage. J. Biol. Chem. 1996, 271:26616-26621.
45. Helfrich W. Elastic properties of lipid bilayers: theory and possible experiments. Z. Naturforsch. [C] 1973, 28:693-703.
46. Goni F.M., Alonso A. Membrane fusion induced by phospholipase C and sphingomyelinases. Biosci. Rep. 2000, 20:443-463.
47. Chernomordik L.V., Zimmerberg J. Bending membranes to the task: structural intermediates in bilayer fusion. Curr. Opin. Struct. Biol. 1995, 5:541-547.
48. Basanez G., Ruiz-Arguello M.B., Alonso A., Goni F.M., Karlsson G., Edwards K. Morphological changes induced by phospholipase C and by sphingomyelinase on large unilamellar vesicles: a cryo-transmission electron microscopy study of liposome fusion. Biophys. J. 1997, 72:2630-2637.
49. Holopainen J.M., Angelova M.I., Kinnunen P.K. Vectorial budding of vesicles by asymmetrical enzymatic formation of ceramide in giant liposomes. Biophys. J. 2000, 78:830-838.
50. Zha X., Pierini L.M., Leopold P.L., Skiba P.J., Tabas I., Maxfield F.R. Sphingomyelinase treatment induces ATP-independent endocytosis. J. Cell Biol. 1998, 140:39-47.
51. Rogasevskaia T., Coorssen J.R. Sphingomyelin-enriched microdomains define the efficiency of native Ca(2+)-triggered membrane fusion. J. Cell Sci. 2006, 119:2688-2694.
52. Grassme H., Becker K.A., Zhang Y., Gulbins E. Ceramide in bacterial infections and cystic fibrosis. Biol. Chem. 2008, 389:1371-1379.
53. Montes L.R., Ruiz-Arguello M.B., Goni F.M., Alonso A. Membrane restructuring via ceramide results in enhanced solute efflux. J. Biol. Chem. 2002, 277:11788-11794.
54. Siskind L.J., Colombini M. The lipids C2- and C16-ceramide form large stable channels. Implications for apoptosis. J. Biol. Chem. 2000, 275:38640-38644.
55. Siskind L.J., Kolesnick R.N., Colombini M. Ceramide forms channels in mitochondrial outer membranes at physiologically relevant concentrations. Mitochondrion 2006, 6:118-125.
56. Siskind L.J., et al. Anti-apoptotic Bcl-2 family proteins disassemble ceramide channels. J. Biol. Chem. 2008, 283:6622-6630.
57. Anishkin A., Sukharev S., Colombini M. Searching for the molecular arrangement of transmembrane ceramide channels. Biophys. J. 2006, 90:2414-2426.
58. Papahadjopoulos D., Cowden M., Kimelberg H. Role of cholesterol in membranes. Effects on phospholipid-protein interactions, membrane permeability and enzymatic activity. Biochim. Biophys. Acta 1973, 330:8-26.
59. Bai J., Pagano R.E. Measurement of spontaneous transfer and transbilayer movement of BODIPY-labeled lipids in lipid vesicles. Biochemistry 1997, 36:8840-8848.
60. Lopez-Montero I., Rodriguez N., Cribier S., Pohl A., Velez M., Devaux P.F. Rapid transbilayer movement of ceramides in phospholipid vesicles and in human erythrocytes. J. Biol. Chem. 2005, 280:25811-25819.
61. Contreras F.X., Villar A.V., Alonso A., Kolesnick R.N., Goni F.M. Sphingomyelinase activity causes transbilayer lipid translocation in model and cell membranes. J. Biol. Chem. 2003, 278:37169-37174.
62. Contreras F.X., Basanez G., Alonso A., Herrmann A., Goni F.M. Asymmetric addition of ceramides but not dihydroceramides promotes transbilayer (flip-flop) lipid motion in membranes. Biophys. J. 2005, 88:348-359.
63. Cremesti A.E., Goni F.M., Kolesnick R. Role of sphingomyelinase and ceramide in modulating rafts: do biophysical properties determine biologic outcome?. FEBS Lett. 2002, 531:47-53.
64. Liu P., Anderson R.G. Compartmentalized production of ceramide at the cell surface. J. Biol. Chem. 1995, 270:27179-27185.
65. Ferlinz K., Hurwitz R., Vielhaber G., Suzuki K., Sandhoff K. Occurrence of two molecular forms of human acid sphingomyelinase. Biochem. J. 1994, 301(Pt 3):855-862.
66. Schissel S.L., Keesler G.A., Schuchman E.H., Williams K.J., Tabas I. The cellular trafficking and zinc dependence of secretory and lysosomal sphingomyelinase, two products of the acid sphingomyelinase gene. J. Biol. Chem. 1998, 273:18250-18259.
67. Lansmann S., Ferlinz K., Hurwitz R., Bartelsen O., Glombitza G., Sandhoff K. Purification of acid sphingomyelinase from human placenta: characterization and N-terminal sequence. FEBS Lett. 1996, 399:227-231.
68. Marathe S., Schissel S.L., Yellin M.J., Beatini N., Mintzer R., Williams K.J., Tabas I. Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase. Implications for early atherogenesis and ceramide-mediated cell signaling. J. Biol. Chem. 1998, 273:4081-4088.
69. Grassme H., Jekle A., Riehle A., Schwarz H., Berger J., Sandhoff K., Kolesnick R., Gulbins E. CD95 signaling via ceramide-rich membrane rafts. J. Biol. Chem. 2001, 276:20589-20596.
70. Grassme H., Jendrossek V., Gulbins E. Molecular mechanisms of bacteria induced apoptosis. Apoptosis 2001, 6:441-445.
71. Cremesti A., Paris F., Grassme H., Holler N., Tschopp J., Fuks Z., Gulbins E., Kolesnick R. Ceramide enables fas to cap and kill. J. Biol. Chem. 2001, 276:23954-23961.
72. Grassme H., Bock J., Kun J., Gulbins E. Clustering of CD40 ligand is required to form a functional contact with CD40. J. Biol. Chem. 2002, 277:30289-30299.
73. Dumitru C.A., Gulbins E. TRAIL activates acid sphingomyelinase via a redox mechanism and releases ceramide to trigger apoptosis. Oncogene 2006, 25:5612-5625.
74. Schutze S., Potthoff K., Machleidt T., Berkovic D., Wiegmann K., Kronke M. TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced " acidic" sphingomyelin breakdown. Cell 1992, 71:765-776.
75. Garcia-Ruiz C., Colell A., Mari M., Morales A., Calvo M., Enrich C., Fernandez-Checa J.C. Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice. J. Clin. Invest. 2003, 111:197-208.
76. Haimovitz-Friedman A., et al. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J. Exp. Med. 1997, 186:1831-1841.
77. Pfeiffer A., et al. Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts. Eur. J. Immunol. 2001, 31:3153-3164.
78. Erdreich-Epstein A., Tran L.B., Cox O.T., Huang E.Y., Laug W.E., Shimada H., Millard M. Endothelial apoptosis induced by inhibition of integrins alphavbeta3 and alphavbeta5 involves ceramide metabolic pathways. Blood 2005, 105:4353-4361.
79. Goggel R., et al. PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide. Nat. Med. 2004, 10:155-160.
80. Zhang Y., et al. Involvement of the acid sphingomyelinase pathway in uva-induced apoptosis. J. Biol. Chem. 2001, 276:11775-11782.
81. Charruyer A., Grazide S., Bezombes C., Muller S., Laurent G., Jaffrezou J.P. UV-C light induces raft-associated acid sphingomyelinase and JNK activation and translocation independently on a nuclear signal. J. Biol. Chem. 2005, 280:19196-19204.
82. Rotolo J.A., Zhang J., Donepudi M., Lee H., Fuks Z., Kolesnick R. Caspase-dependent and -independent activation of acid sphingomyelinase signaling. J. Biol. Chem. 2005, 280:26425-26434.
83. Kashkar H., Wiegmann K., Yazdanpanah B., Haubert D., Kronke M. Acid sphingomyelinase is indispensable for UV light-induced Bax conformational change at the mitochondrial membrane. J. Biol. Chem. 2005, 280:20804-20813.
84. Chung H.S., Park S.R., Choi E.K., Park H.J., Griffin R.J., Song C.W., Park H. Role of sphingomyelin-MAPKs pathway in heat-induced apoptosis. Exp. Mol. Med. 2003, 35:181-188.
85. Verheij M., et al. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 1996, 380:75-79.
86. Sanvicens N., Cotter T.G. Ceramide is the key mediator of oxidative stress-induced apoptosis in retinal photoreceptor cells. J. Neurochem. 2006, 98:1432-1444.
87. Lacour S., et al. Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells. Cancer Res. 2004, 64:3593-3598.
88. Modrak D.E., Cardillo T.M., Newsome G.A., Goldenberg D.M., Gold D.V. Synergistic interaction between sphingomyelin and gemcitabine potentiates ceramide-mediated apoptosis in pancreatic cancer. Cancer Res. 2004, 64:8405-8410.
89. Morita Y., et al. Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat. Med. 2000, 6:1109-1114.
90. Paris F., et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 2001, 293:293-297.
91. Santana P., et al. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 1996, 86:189-199.
92. Lang P.A., et al. Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat. Med. 2007, 13:164-170.
93. Grassme H., Gulbins E., Brenner B., Ferlinz K., Sandhoff K., Harzer K., Lang F., Meyer T.F. Acidic sphingomyelinase mediates entry of N. Gonorrhoeae into non-phagocytic cells. Cell 1997, 91:605-615.
94. Grassme H., et al. Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat. Med. 2003, 9:322-330.
95. Esen M., Schreiner B., Jendrossek V., Lang F., Fassbender K., Grassme H., Gulbins E. Mechanisms of Staphylococcus aureus induced apoptosis of human endothelial cells. Apoptosis 2001, 6:431-439.
96. Grassme H., Riehle A., Wilker B., Gulbins E. Rhinoviruses infect human epithelial cells via ceramide-enriched membrane platforms. J. Biol. Chem. 2005, 280:26256-26262.
97. Jan J.T., Chatterjee S., Griffin D.E. Sindbis virus entry into cells triggers apoptosis by activating sphingomyelinase, leading to the release of ceramide. J. Virol. 2000, 74:6425-6432.
98. Bezombes C., Grazide S., Garret C., Fabre C., Quillet-Mary A., Muller S., Jaffrezou J.P., Laurent G. Rituximab antiproliferative effect in B-lymphoma cells is associated with acid-sphingomyelinase activation in raft microdomains. Blood 2004, 104:1166-1173.
99. Mathias S., Younes A., Kan C.C., Orlow I., Joseph C., Kolesnick R.N. Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1 beta. Science 1993, 259:519-522.
100. Simarro M., Calvo J., Vila J.M., Places L., Padilla O., Alberola-Ila J., Vives J., Lozano F. Signaling through CD5 involves acidic sphingomyelinase, protein kinase C-zeta, mitogen-activated protein kinase kinase, and c-Jun NH2-terminal kinase. J. Immunol. 1999, 162:5149-5155.
101. Boucher L.M., Wiegmann K., Futterer A., Pfeffer K., Machleidt T., Schutze S., Mak T.W., Kronke M. CD28 signals through acidic sphingomyelinase. J. Exp. Med. 1995, 181:2059-2068.
102. Ni H.T., Deeths M.J., Li W., Mueller D.L., Mescher M.F. Signaling pathways activated by leukocyte function-associated Ag-1-dependent costimulation. J. Immunol. 1999, 162:5183-5189.
103. Abdel Shakor A.B., Kwiatkowska K., Sobota A. Cell surface ceramide generation precedes and controls FcgammaRII clustering and phosphorylation in rafts. J. Biol. Chem. 2004, 279:36778-36787.
104. Grassme H., Schwarz H., Gulbins E. Molecular mechanisms of ceramide-mediated CD95 clustering. Biochem. Biophys. Res. Commun. 2001, 284:1016-1030.
105. Gulbins E., et al. FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity 1995, 2:341-351.
106. Grassme H., Cremesti A., Kolesnick R., Gulbins E. Ceramide-mediated clustering is required for CD95-DISC formation. Oncogene 2003, 22:5457-5470.
107. Brenner B., et al. Fas/CD95/Apo-I activates the acidic sphingomyelinase via caspases. Cell Death. Differ. 1998, 5:29-37.
108. Schwandner R., Wiegmann K., Bernardo K., Kreder D., Kronke M. TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase. J. Biol. Chem. 1998, 273:5916-5922.
109. Qiu H., Edmunds T., Baker-Malcolm J., Karey K.P., Estes S., Schwarz C., Hughes H., Van Patten S.M. Activation of human acid sphingomyelinase through modification or deletion of C-terminal cysteine. J. Biol. Chem. 2003, 278:32744-32752.
110. Bionda C., Hadchity E., Alphonse G., Chapet O., Rousson R., Rodriguez-Lafrasse C., Ardail D. Radioresistance of human carcinoma cells is correlated to a defect in raft membrane clustering. Free Radic. Biol. Med. 2007, 43:681-694.
111. Fanzo J.C., et al. CD95 rapidly clusters in cells of diverse origins. Cancer Biol. Ther. 2003, 2:392-395.
112. Simons K., Ikonen E. Functional rafts in cell membranes. Nature 1997, 387:569-572.
113. Harder T., Simons K. Caveolae, DIGs, and the dynamics of sphingolipid-cholesterol microdomains. Curr. Opin. Cell Biol. 1997, 9:534-542.
114. Brown D.A., London E. Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 1998, 14:111-136.
115. Keller P., Simons K. Cholesterol is required for surface transport of influenza virus hemagglutinin. J. Cell Biol. 1998, 140:1357-1367.
116. Contreras F.X., Sot J., Ruiz-Arguello M.B., Alonso A., Goni F.M. Cholesterol modulation of sphingomyelinase activity at physiological temperatures. Chem. Phys. Lipids 2004, 130:127-134.
117. Bock J., Gulbins E. The transmembranous domain of CD40 determines CD40 partitioning into lipid rafts. FEBS Lett. 2003, 534:169-174.
118. Grassme H., Jendrossek V., Bock J., Riehle A., Gulbins E. Ceramide-rich membrane rafts mediate CD40 clustering. J. Immunol. 2002, 168:298-307.
119. Cahuzac N., et al. Fas ligand is localized to membrane rafts, where it displays increased cell death-inducing activity. Blood 2006, 107:2384-2391.
120. Huwiler A., Johansen B., Skarstad A., Pfeilschifter J. Ceramide binds to the CaLB domain of cytosolic phospholipase A2 and facilitates its membrane docking and arachidonic acid release. FASEB J. 2001, 15:7-9.
121. Zhang Y., et al. Kinase suppressor of Ras is ceramide-activated protein kinase. Cell 1997, 89:63-72.
122. Dobrowsky R.T., Hannun Y.A. Ceramide-activated protein phosphatase: partial purification and relationship to protein phosphatase 2A. Adv. Lipid Res. 1993, 25:91-104.
123. Heinrich M., et al. Cathepsin D targeted by acid sphingomyelinase-derived ceramide. EMBO J. 1999, 18:5252-5263.
124. Yao B., Zhang Y., Delikat S., Mathias S., Basu S., Kolesnick R. Phosphorylation of Raf by ceramide-activated protein kinase. Nature 1995, 378:307-310.
125. Yin X., Zafrullah M., Lee H., Haimovitz-Friedman A., Fuks Z., Kolesnick R. A ceramide-binding C1 domain mediates kinase suppressor of ras membrane translocation. Cell Physiol. Biochem. 2009, 24:219-230.
126. Rajendran L., Simons K. Lipid rafts and membrane dynamics. J. Cell Sci. 2005, 118:1099-1102.
127. Riethmuller J., Riehle A., Grassme H., Gulbins E. Membrane rafts in host-pathogen interactions. Biochim. Biophys. Acta 2006, 1758:2139-2147.
128. Uhlig S., Gulbins E. Sphingolipids in the lungs. Am. J. Respir. Crit. Care Med. 2008, 178:1100-1114.
129. Garcia-Barros M., Paris F., Cordon-Cardo C., Lyden D., Rafii S., Haimovitz-Friedman A., Fuks Z., Kolesnick R. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 2003, 300:1155-1159.
130. Smith E.L., Schuchman E.H. Acid sphingomyelinase overexpression enhances the antineoplastic effects of irradiation in vitro and in vivo. Mol Ther. 2008, 16:1565-1571.
131. Paris F., et al. Sphingosine 1-phosphate preserves fertility in irradiated female mice without propagating genomic damage in offspring. Nat. Med. 2002, 8:901-902.
132. Rotolo J.A., et al. Cytolytic T cells induce ceramide-rich platforms in target cell membranes to initiate graft-versus-host disease. Blood 2009, 114:3693-3706.
133. Teichgraber V., et al. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat. Med. 2008, 14:382-391.
134. Riethmuller J., Anthonysamy J., Serra E., Schwab M., Doring G., Gulbins E. Therapeutic efficacy and safety of amitriptyline in patients with cystic fibrosis. Cell Physiol. Biochem. 2009, 24:65-72.
135. Scheel-Toellner D., et al. Reactive oxygen species limit neutrophil life span by activating death receptor signaling. Blood 2004, 104:2557-2564.
136. Zhang A.Y., Yi F., Zhang G., Gulbins E., Li P.L. Lipid raft clustering and redox signaling platform formation in coronary arterial endothelial cells. Hypertension 2006, 47:74-80.
137. Zhang A.Y., Yi F., Jin S., Xia M., Chen Q.Z., Gulbins E., Li P.L. Acid sphingomyelinase and its redox amplification in formation of lipid raft redox signaling platforms in endothelial cells. Antioxid. Redox Signal. 2007, 9:817-828.
138. Jin S., Yi F., Zhang F., Poklis J.L., Li P.L. Lysosomal targeting and trafficking of acid sphingomyelinase to lipid raft platforms in coronary endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2008, 28:2056-2062.
139. Jin S., Zhang Y., Yi F., Li P.L. Critical role of lipid raft redox signaling platforms in endostatin-induced coronary endothelial dysfunction. Arterioscler. Thromb. Vasc. Biol. 2008, 28:485-490.
140. Xia M., Wang Q., Zhu H., Ma J., Hou M., Tang Z., Li J., Ling W. Lipid rafts regulate cellular CD40 receptor localization in vascular endothelial cells. Biochem. Biophys. Res. Commun. 2007, 361:768-774.
141. Zhang Y., Li X., Carpinteiro A., Gulbins E. Acid sphingomyelinase amplifies redox signaling in Pseudomonas aeruginosa-induced macrophage apoptosis. J. Immunol. 2008, 181:4247-4254.
142. Dreschers S., Franz P., Dumitru C., Wilker B., Jahnke K., Gulbins E. Infections with human rhinovirus induce the formation of distinct functional membrane domains. Cell Physiol. Biochem. 2007, 20:241-254.
143. Gajate C., Mollinedo F. The antitumor ether lipid ET-18-OCH(3) induces apoptosis through translocation and capping of Fas/CD95 into membrane rafts in human leukemic cells. Blood 2001, 98:3860-3863.
144. Cuschieri J., Bulger E., Billgrin J., Garcia I., Maier R.V. Acid sphingomyelinase is required for lipid Raft TLR4 complex formation. Surg. Infect. (Larchmt) 2007, 8:91-106.
145. Jia S.J., Jin S., Zhang F., Yi F., Dewey W.L., Li P.L. Formation and function of ceramide-enriched membrane platforms with CD38 during M1-receptor stimulation in bovine coronary arterial myocytes. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H1743-H1752.
146. Yu Z.F., Nikolova-Karakashian M., Zhou D., Cheng G., Schuchman E.H., Mattson M.P. Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis. J. Mol. Neurosci. 2000, 15:85-97.
147. Marathe S., Kuriakose G., Williams K.J., Tabas I. Sphingomyelinase, an enzyme implicated in atherogenesis, is present in atherosclerotic lesions and binds to specific components of the subendothelial extracellular matrix. Arterioscler. Thromb. Vasc. Biol. 1999, 19:2648-2658.
148. Doehner W., et al. Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow. Eur. Heart J. 2007, 28:821-828.
149. Gorska M., Baranczuk E., Dobrzyn A. Secretory Zn2+-dependent sphingomyelinase activity in the serum of patients with type 2 diabetes is elevated. Horm. Metab. Res. 2003, 35:506-507.
150. Powell D.J., Turban S., Gray A., Hajduch E., Hundal H.S. Intracellular ceramide synthesis and protein kinase Czeta activation play an essential role in palmitate-induced insulin resistance in rat L6 skeletal muscle cells. Biochem. J. 2004, 382:619-629.
151. Holland W.L., et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab. 2007, 5:167-179.
152. Liao W.C., et al. Ataxia telangiectasia-mutated gene product inhibits DNA damage-induced apoptosis via ceramide synthase. J. Biol. Chem. 1999, 274:17908-17917.
153. Truman J.P., Gueven N., Lavin M., Leibel S., Kolesnick R., Fuks Z., Haimovitz-Friedman A. Down-regulation of ATM protein sensitizes human prostate cancer cells to radiation-induced apoptosis. J. Biol. Chem. 2005, 280:23262-23272.
154. Esen M., Grassme H., Riethmuller J., Riehle A., Fassbender K., Gulbins E. Invasion of human epithelial cells by Pseudomonas aeruginosa involves src-like tyrosine kinases p60Src and p59Fyn. Infect Immun. 2001, 69:281-287.
155. Claus R.A., Bunck A.C., Bockmeyer C.L., Brunkhorst F.M., Losche W., Kinscherf R., Deigner H.P. Role of increased sphingomyelinase activity in apoptosis and organ failure of patients with severe sepsis. FASEB J. 2005, 19:1719-1721.
156. Petrache I., et al. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat. Med. 2005, 11:491-498.
157. Seino K., Kayagaki N., Takeda K., Fukao K., Okumura K., Yagita H. Contribution of Fas ligand to T cell-mediated hepatic injury in mice. Gastroenterology 1997, 113:1315-1322.
158. He X., Huang Y., Li B., Gong C.X., Schuchman E.H. Deregulation of sphingolipid metabolism in Alzheimer's disease. Neurobiol Aging. 2008, 31:398-408.
159. Stiban J., Fistere D., Colombini M. Dihydroceramide hinders ceramide channel formation: Implications on apoptosis. Apoptosis 2006, 11:773-780.